Inhalator

Patent europeic · EP2865403 · En vigur

Inscripziun en il register

Numer da publicaziun
EP2865403
Numer da la dumonda
EP14198936
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
13-03-2012
Publitgà
29-04-2015
Concedì
15-06-2016
La protecziun finescha il pli tard
12-03-2032
Proxima taxa annuala scadenta
31-03-2027
Classas IPC
A61M 15/00 (2006.01)
Prioritad
US 201161452763 P 15.03.2011
Derivà da
EP12711598
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 01-04-2026

    Midada

    Published in Swissreg on 01.04.2026

  2. 01-04-2025

    Midada

    Published in Swissreg on 01.04.2025

  3. 01-04-2024

    Midada

    Published in Swissreg on 01.04.2024

  4. 01-04-2023

    Midada

    Published in Swissreg on 01.04.2023

  5. 15-06-2016

    Concedì

    Published in Swissreg on 15.06.2016

Partidas

Possessur

Novartis AG

Lichtstrasse 35, 4056 Basel

Inventur

Hosemann, Michael

Cambridge, Cambridgeshire CB40DW, GB

Phillips, Desmond

Cambridge, Cambridgeshire CB40DW, GB

Ramble, David

Cambridge, Cambridgeshire CB40DW, GB

Reynolds, Sean

West Sussex, GU29 9AZ, GB

Vernon-Harcourt, Edward

West Sussex, Bn44 3 LG, GB

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.